For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading ->
The COVID-19 pandemic underscored the risks of over-reliance on global supply chains for essential health products. Disruptions led to severe delays and shortages of vaccines, therapeutics, and diagnostics, with low- and middle-income countries bearing the brunt. Vaccine inequality starkly highlighted Africa’s vulnerability. Yet this crisis unveiled a unique opportunity for the continent: a chance to […] Continue reading ->
The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading ->
While this week’s CARICOM summit in Grenada has been postponed due to Hurricane Beryl, when it does convenes, a key item on the agenda will be the new ‘HeDPAC’ initiative to deepen South-South partnerships to meet shared global health challenges – from pandemic threats to climate change. In remote communities of Guyana, the introduction of […] Continue reading ->
GENEVA – Partnerships between industry, multilateral organizations, and other stakeholders are essential to overcoming challenges and improving access to innovations. This was the key message at an International Federation of Pharmaceutical Manufacturers (IFPMA) event on Tuesday evening, held on the sidelines of the World Health Assembly in Geneva. The gathering brought together representatives from the […] Continue reading ->
Insulin pens are more affordable and preferred by diabetics but they are available almost exclusively in high-income countries due to gross overpricing, according to a report by Médecins Sans Frontières (MSF) and T1International, a British NGO fighting for equal treatment access for people with diabetes type 1. The research was presented on Wednesday, ahead of […] Continue reading ->
Demand for diabetes drugs such as Wegovy, Ozempic, Rybelsis and Trulicity has soared since they have been clinically proven to help weight loss – but they are massively overpriced in the US and unavailable in most low- and middle-income countries (LMIC), according to Médecins Sans Frontières (MSF). The mark-up for these drugs – called glucagon-like […] Continue reading ->
The negotiating text of the pandemic agreement (see below) landed in the inboxes of World Health Organization (WHO) member states last Friday afternoon – 10 days before the penultimate negotiation on 18 March and on the eve of the fourth anniversary of the WHO’s declaration of COVID-19 as a pandemic. The 31-page draft was also […] Continue reading ->
The European Parliament has been challenged to amend a proposed law to enable countries outside the European Union (EU) to benefit from medical products produced under compulsory licences during crises. The proposed regulation aims to ensure that, “during specific crises or emergencies”, the EU can issue a compulsory licence to enable the production of certain […] Continue reading ->
The Africa Centres for Disease Control and Prevention (Africa CDC), has announced the creation of a pooled African medicines procurement mechanism at the 37th African Union Summit, which ended yesterday. The mechanism aims to spearhead “a new era of predictable demand for African manufacturers, empowering them to plan for the long-term and establish a robust […] Continue reading ->